Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 5178631, 12 pages
https://doi.org/10.1155/2017/5178631
Review Article

Valve Calcification in Aortic Stenosis: Etiology and Diagnostic Imaging Techniques

1Department of Cardiology, Hospital Universitario de Canarias, Tenerife, Spain
2Servicios Sanitarios del Área de Salud de El Hierro, Valle del Golfo Health Center, El Hierro, Spain

Correspondence should be addressed to Juan Lacalzada-Almeida; moc.liamg@adazlacalj

Received 5 April 2017; Accepted 20 June 2017; Published 24 July 2017

Academic Editor: Giacomina Brunetti

Copyright © 2017 María Manuela Izquierdo-Gómez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Lindroos, M. Kupari, J. Heikkila, and R. Tilvis, “Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample,” Journal of the American College of Cardiology, vol. 21, no. 5, pp. 1220–1225, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. B. F. Stewart, D. Siscovick, B. K. Lind et al., “Clinical factors associated with calcific aortic valve disease,” Journal of the American College of Cardiology, vol. 29, no. 3, pp. 630–634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. W. C. Roberts, “The senile cardiac calcification syndrome,” The American Journal of Cardiology, vol. 58, no. 6, pp. 572–574, 1986. View at Publisher · View at Google Scholar · View at Scopus
  4. E. R. Mohler, R. Nichols, W. P. Harvey, M. J. Sheridan, B. F. Waller, and B. F. Waller, “Development and progression of aortic valve stenosis: Atherosclerosis risk factors—a causal relationship? a clinical morphologic study,” Clinical Cardiology, vol. 14, no. 12, pp. 995–999, 1991. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Deutscher, H. E. Rockette, and V. Krishnaswami, “Diabetes and hypercholesterolemia among patients with calcific aortic stenosis,” Journal of Chronic Diseases, vol. 37, no. 5, pp. 407–415, 1984. View at Publisher · View at Google Scholar · View at Scopus
  6. W. S. Aronow, K. S. Schwartz, and M. Koenigsberg, “Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients,” The American Journal of Cardiology, vol. 59, no. 9, pp. 998-999, 1987. View at Publisher · View at Google Scholar · View at Scopus
  7. C. S. Fox, R. S. Vasan, H. Parise et al., “Mitral annular calcification predicts cardiovascular morbidity and mortality: The Framingham Heart Study,” Circulation, vol. 107, no. 11, pp. 1492–1496, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Farzaneh-Far, D. Proudfoot, C. Shanahan, and P. L. Weissberg, “Vascular and valvar calcification: recent advances,” Heart, vol. 85, no. 1, pp. 13–17, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. W. S. Aronow, C. Ahn, and I. Kronzon, “Association of mitral annular calcium and of aortic cuspal calcium with coronary artery disease in older patients,” American Journal of Cardiology, vol. 84, no. 9, pp. 1084-1085, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Otto, B. Lind, and D. Kitzman, “Association of aortic valve sclerosis with cardiovascular mortality and morbidity in the elderly,” The New England Journal of Medicine, vol. 341, no. 10, pp. 142–147, 1999. View at Publisher · View at Google Scholar
  11. A. Boon, E. Cheriex, J. Lodder, and F. Kessels, “Cardiac valve calcification: Characteristics of patients with calcification of the mitral annulus or aortic valve,” Heart, vol. 78, no. 5, pp. 472–474, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. D. S. Owens, M. J. Budoff, R. Katz et al., “Aortic Valve Calcium Independently Predicts Coronary and Cardiovascular Events in a Primary Prevention Population: Multi-Ethnic Study of Atherosclerosis [MESA],” Journal of the American College of Cardiology (JACC): Cardiovascular Imaging, vol. 5, no. 6, pp. 619–625, 2012. View at Publisher · View at Google Scholar
  13. C. Iribarren, S. Sidney, B. Sternfeld, and W. S. Browner, “Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease,” Journal of the American Medical Association, vol. 283, no. 21, pp. 2810–2815, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Tenenbaum, J. Shemesh, E. Z. Fisman, and M. Motro, “Advanced mitral annular calcification is associated with severe coronary calcification on fast dual spiral computed tomography,” Investigative Radiology, vol. 35, no. 3, pp. 193–198, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. J. R. A. Mitchell and C. J. Schwartz, “Relationship between arterial disease in different sites,” British Medical Journal, vol. 1, no. 5288, pp. 1293–1301, 1962. View at Publisher · View at Google Scholar · View at Scopus
  16. G. S. Pressman, V. Crudu, A. Parameswaran-Chandrika, A. Romero-Corral, B. Purushottam, and V. M. Figueredo, “Can total cardiac calcium predict the coronary calcium score?” International Journal of Cardiology, vol. 146, no. 2, pp. 202–206, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. A. Strickberger, S. P. Schulman, and G. M. Hutchins, “Association of Paget's disease of bone with calcific aortic valve disease,” The American Journal of Medicine, vol. 82, no. 5, pp. 953–956, 1987. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Aksoy, C. Yagmur, G. O. Tekin et al., “Aortic valve calcification: Association with bone mineral density and cardiovascular risk factors,” Coronary Artery Disease, vol. 16, no. 6, pp. 379–383, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. G. M. London, S. J. Marchais, A. P. Guérin, and F. Métivier, “Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia,” Current Opinion in Nephrology and Hypertension, vol. 14, no. 6, pp. 525–531, 2005. View at Publisher · View at Google Scholar
  20. J. Takasu, R. Katz, K. Nasir et al., “Relationships of thoracic aortic wall calcification to cardiovascular risk factors: The Multi-Ethnic Study of Atherosclerosis (MESA),” American Heart Journal, vol. 155, no. 4, pp. 765–771, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. D.-S. Jeon, S. Atar, A. V. Brasch et al., “Association of mitral annulus calcification, aortic valve sclerosis and aortic root calcification with abnormal myocardial perfusion single photon emission tomography in subjects age ≤65 years old,” Journal of the American College of Cardiology, vol. 38, no. 7, pp. 1988–1993, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Soydinc, V. Davutoglu, A. Dundar, and M. Aksoy, “Relationship between aortic valve sclerosis and the extent of coronary artery disease in patients undergoing diagnostic coronary angiography,” Cardiology, vol. 106, no. 4, pp. 277–282, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Nucifora, J. D. Schuijf, J. M. van Werkhoven et al., “Usefulness of Echocardiographic Assessment of Cardiac and Ascending Aorta Calcific Deposits to Predict Coronary Artery Calcium and Presence and Severity of Obstructive Coronary Artery Disease,” American Journal of Cardiology, vol. 103, no. 8, pp. 1045–1050, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. A. I. Corciu, V. Siciliano, E. Poggianti, C. Petersen, L. Venneri, and E. Picano, “Cardiac calcification by transthoracic echocardiography in patients with known or suspected coronary artery disease,” International Journal of Cardiology, vol. 142, no. 3, pp. 288–295, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Lacalzada, A. De La Rosa, J. J. Jiménez et al., “Prognostic value of echocardiographic-derived calcium index in coronary artery disease diagnosed by 64-multidetector computed tomography,” Echocardiography, vol. 29, no. 9, pp. 1120–1127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. S. J. Cowell, D. E. Newby, N. A. Boon, and A. T. Elder, “Calcific aortic stenosis: Same old story?” Age and Ageing, vol. 33, no. 6, pp. 538–544, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. K. D. O'Brien, D. D. Reichenbach, S. M. Marcovina, J. Kuusisto, C. E. Alpers, and C. M. Otto, “Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 4, pp. 523–532, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Olsson, M. Rosenqvist, and J. Nilsson, “Expression of HLA-DR antigen and smooth muscle cell differentiation markers by valvular fibroblasts in degenerative aortic stenosis,” Journal of the American College of Cardiology, vol. 24, no. 7, pp. 1664–1671, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Wang and T. M. Bashore, “Calcific aortic valve disease: not simply a degenerative valvular process,” Circulation, vol. 124, pp. 1783–1791, 2011. View at Publisher · View at Google Scholar
  30. R. V. Freeman and C. M. Otto, “Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies,” Circulation, vol. 111, no. 24, pp. 3316–3326, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Yetkin and J. Waltenberger, “Molecular and cellular mechanisms of aortic stenosis,” International Journal of Cardiology, vol. 135, no. 1, pp. 4–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. G. H. Gibbons and V. J. Dzau, “Molecular therapies for vascular diseases,” Science, vol. 272, no. 5262, pp. 689–693, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. N. M. Rajamannan, M. Subramaniam, S. R. Stock et al., “Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve,” Heart, vol. 91, no. 6, pp. 806–810, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. N. M. Rajamannan, “Low-density lipoprotein and aortic stenosis,” Heart, vol. 94, no. 9, pp. 1111-1112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. M. R. Dweck, N. A. Boon, and D. E. Newby, “Calcific aortic stenosis: a disease of the valve and the myocardium,” Journal of the American College of Cardiology, vol. 60, no. 19, pp. 1854–1863, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. N. M. Rajamannan, “Bicuspid aortic valve disease: The role of oxidative stress in Lrp5 bone formation,” Cardiovascular Pathology, vol. 20, no. 3, pp. 168–176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Olsson, J. Thyberg, and J. Nilsson, “Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 5, pp. 1218–1222, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Toro, A. Mangas, and F. Gómez, “Enfermedad de la válvula aórtica calcificada. Su asociación con la arteriosclerosis,” Medicina Clínica Facultad de Medicina de Barcelona, vol. 136, no. 13, pp. 588–593, 2011. View at Publisher · View at Google Scholar
  39. E. R. Mohler, M. K. Chawla, A. W. Chang et al., “Identification and characterization of calcifying valve cells from human and canine aortic valves,” Journal of Heart Valve Disease, vol. 8, no. 3, pp. 254–260, 1999. View at Google Scholar · View at Scopus
  40. L. M. Moura, S. F. Ramos, J. L. Zamorano et al., “Rosuvastatin Affecting Aortic Valve Endothelium to Slow the Progression of Aortic Stenosis,” Journal of the American College of Cardiology, vol. 49, no. 5, pp. 554–561, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. S. J. Cowell, D. E. Newby, R. J. Prescott et al., “A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis,” New England Journal of Medicine, vol. 352, no. 23, pp. 2389–2397, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. K. L. Chan, K. Teo, J. G. Dumesnil, A. Ni, and J. Tam, “Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial,” Circulation, vol. 121, no. 2, pp. 306–314, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. C. M. Otto, J. Kuusisto, D. D. Reichenbach, A. M. Gown, and K. D. O'Brien, “Characterization of the early lesion of “degenerative” valvular aortic stenosis: histological and immunohistochemical studies,” Circulation, vol. 90, no. 2, pp. 844–853, 1994. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Wallby, B. Janerot-Sjöberg, T. Steffensen, and M. Broqvist, “T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves,” Heart, vol. 88, no. 4, pp. 348–351, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. N. M. Rajamannan, M. Subramaniam, D. Rickard et al., “Human aortic valve calcification is associated with an osteoblast phenotype,” Circulation, vol. 107, no. 17, pp. 2181–2184, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. J. J. Kaden, C.-E. Dempfle, and R. Grobholz, “Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis,” Atherosclerosis, vol. 170, no. 2, pp. 205–211, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Ferrara and T. Davis-Smith, “The biology of vascular endotelial growth factor,” Endocrine Reviews, vol. 18, pp. 4–25, 1997. View at Google Scholar
  48. J. J. Kaden, C.-E. Dempfle, R. Grobholz et al., “Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis,” Cardiovascular Pathology, vol. 14, no. 2, pp. 80–87, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. JJ. Kaden, S. Bickelhaupt, R. Grobholz et al., “Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis,” The Journal of Heart Valve Disease, vol. 13, pp. 560–566, 2004. View at Google Scholar
  50. J.-H. Chen and C. A. Simmons, “Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues,” Circulation Research, vol. 108, no. 12, pp. 1510–1524, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. P. J. Cawley and C. M. Otto, “Prevention of calcific aortic valve stenosis - Fact or fiction?” Annals of Medicine, vol. 41, no. 2, pp. 100–108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. D. A. Towler, “Molecular and cellular aspects of calcific aortic valve disease,” Circulation Research, vol. 113, no. 2, pp. 198–208, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. M. A. Bratos-Pérez, P. L. Sánchez, S. García De Cruz et al., “Association between self-replicating calcifying nanoparticles and aortic stenosis: A possible link to valve calcification,” European Heart Journal, vol. 29, no. 3, pp. 371–376, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. T. M. Jelic, H.-H. Chang, R. Roque, A. M. Malas, S. G. Warren, and A. P. Sommer, “Nanobacteriaassociated calcific aortic valve stenosis,” The Journal of Heart Valve Disease, vol. 16, no. 1, pp. 101–105, 2007. View at Google Scholar · View at Scopus
  55. S. Helske, K. A. Lindstedt, M. Laine et al., “Induction of local angiotensin II-producing systems in stenotic aortic valves,” Journal of the American College of Cardiology, vol. 44, no. 9, pp. 1859–1866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. K. D. O'Brien, J. L. Probstfield, M. T. Caulfield et al., “Angiotensin-converting enzyme inhibitors and change in aortic valve calcium,” Archives of Internal Medicine, vol. 165, no. 8, pp. 858–862, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Rosenhek, F. Rader, N. Loho et al., “Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis,” Circulation, vol. 110, no. 10, pp. 1291–1295, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. J. R. Ortlepp, R. Hoffmann, F. Ohme, J. Lauscher, F. Bleckmann, and P. Hanrath, “The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis,” Heart, vol. 85, no. 6, pp. 635–638, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Bossé, P. Mathieu, and P. Pibarot, “Genomics. The Next Step to Elucidate the Etiology of Calcific Aortic Valve Stenosis,” Journal of the American College of Cardiology, vol. 51, no. 14, pp. 1327–1336, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. R. Capoulade and P. Pibarot, “Assessment of Aortic Valve Disease: Role of Imaging Modalities,” Current Treatment Options in Cardiovascular Medicine, vol. 17, no. 11, article no. 49, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. RA. Nishimura, “AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines,” Circulation, 2014. View at Google Scholar
  62. R. Rosenhek, T. Binder, G. Porenta et al., “Predictors of outcome in severe, asymptomatic aortic stenosis,” The New England Journal of Medicine, vol. 343, no. 9, pp. 611–617, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Baumgartner, J. Hung, J. Bermejo et al., “Recommendations on the echocardiographic assesment of aortic valve stenosis: a focused update from de European Association of Cardiovascular Imaging and the American Society of Echocardiography,” European Heart Journal – Cardiovascular Imaging, vol. 18, no. 4, pp. 254–275, 2017. View at Publisher · View at Google Scholar
  64. J.-L. Monin, M. Monchi, V. Gest, A.-M. Duval-Moulin, J.-L. Dubois-Rande, and P. Gueret, “Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography,” Journal of the American College of Cardiology, vol. 37, no. 8, pp. 2101–2107, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. R. A. Nishimura, J. A. Grantham, H. M. Connolly, H. V. Schaff, S. T. Higano, and D. R. Holmes Jr., “Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: The clinical utility of the dobutamine challenge in the catheterization laboratory,” Circulation, vol. 106, no. 7, pp. 809–813, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. E. Fougères, C. Tribouilloy, M. Monchi et al., “Outcomes of pseudo-severe aortic stenosis under conservative treatment,” European Heart Journal, vol. 33, no. 19, pp. 2426–2433, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. RA. Nishimura, CM. Otto, RO. Bonow, BA. Carabello, JP. Erwin, and RA. Guyton, in AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, pp. 2440–2492, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 2014.
  68. C. R. deFilippi, D. L. Willett, M. E. Brickner et al., “Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients,” The American Journal of Cardiology, vol. 75, no. 2, pp. 191–194, 1995. View at Publisher · View at Google Scholar · View at Scopus
  69. J.-L. Monin, J.-P. Quéré, M. Monchi et al., “Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics,” in Circulation, vol. 108, pp. 319–324, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. Z. Hachicha, J. G. Dumesnil, P. Bogaty, and P. Pibarot, “Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival,” Circulation, vol. 115, no. 22, pp. 2856–2864, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. P. Pibarot and J. G. Dumesnil, “Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction,” Journal of the American College of Cardiology, vol. 60, no. 19, pp. 1845–1853, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. M.-A. Clavel, D. Messika-Zeitoun, P. Pibarot et al., “The complex nature of discordant severe calcified aortic valve disease grading: New insights from combined Doppler echocardiographic and computed tomographic study,” Journal of the American College of Cardiology, vol. 62, no. 24, pp. 2329–2338, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. V. Dayan, G. Vignolo, J. Magne, M.-A. Clavel, D. Mohty, and P. Pibarot, “Outcome and Impact of Aortic Valve Replacement in Patients with Preserved LVEF and Low-Gradient Aortic Stenosis,” Journal of the American College of Cardiology, vol. 66, no. 23, pp. 2594–2603, 2015. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Minners, M. Allgeier, C. Gohlke-Baerwolf, R.-P. Kienzle, F.-J. Neumann, and N. Jander, “Inconsistent grading of aortic valve stenosis by current guidelines: Haemodynamic studies in patients with apparently normal left ventricular function,” Heart, vol. 96, no. 18, pp. 1463–1468, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. M. F. Eleid, P. Sorajja, H. I. Michelena, J. F. Malouf, C. G. Scott, and P. A. Pellikka, “Flow-gradient patterns in severe aortic stenosis with preserved ejection fraction: Clinical characteristics and predictors of survival,” Circulation, vol. 128, no. 16, pp. 1781–1789, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. F. A. Flachskampf, P. F. Wouters, T. Edvardsen et al., “Recommendations for transoesophageal echocardiography: EACVI update 2014,” European Heart Journal Cardiovascular Imaging, vol. 15, no. 4, pp. 353–365, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. R. A. Greenbaum, S. Y. Ho, D. G. Gibson, A. E. Becker, and R. H. Anderson, “Left ventricular fibre architecture in man,” British Heart Journal, vol. 45, no. 3, pp. 248–263, 1981. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Collier, D. Phelan, and A. Klein, “A test in context: myocardial strain measured by speckle-tracking echocardiography,” Journal of the American College of Cardiology, vol. 69, no. 8, pp. 1043–1056, 2017. View at Publisher · View at Google Scholar
  79. P. Lancellotti, E. Donal, J. Magne et al., “Risk stratification in asymptomatic moderate to severe aortic stenosis: The importance of the valvular, arterial and ventricular interplay,” Heart, vol. 96, no. 17, pp. 1364–1371, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. V. Delgado, L. F. Tops, R. J. Van Bommel et al., “Strain analysis in patients with severe aortic stenosis and preserved left ventricular ejection fraction undergoing surgical valve replacement,” European Heart Journal, vol. 30, no. 24, pp. 3037–3047, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. R. Dulgheru, P. Pibarot, P. P. Sengupta et al., “Multimodality imaging strategies for the assessment of aortic stenosis: Viewpoint of the heart valve clinic international database (HAVEC) group,” Circulation: Cardiovascular Imaging, vol. 9, no. 2, Article ID e004352, 2016. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Elster, “ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology,” Journal of the American College of Cardiology, vol. 48, pp. 9775–9797, 2006. View at Publisher · View at Google Scholar
  83. D. Pennell, U. Sechtem, C. Higgins et al., “Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report,” European Heart Journal, vol. 25, no. 4, pp. 1940–1946, 2004. View at Publisher · View at Google Scholar
  84. T. A. Musa, S. Plein, and J. P. Greenwood, “The role of cardiovascular magnetic resonance in the assessment of severe aortic stenosis and in post-procedural evaluation following transcatheter aortic valve implantation and surgical aortic valve replacement,” Quantitative Imaging in Medicine and Surgery, vol. 6, no. 3, pp. 259–273, 2016. View at Publisher · View at Google Scholar · View at Scopus
  85. S. G. Myerson, “Heart valve disease: Investigation by cardiovascular magnetic resonance,” Journal of Cardiovascular Magnetic Resonance, vol. 14, no. 1, article no. 7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. S. D. Caruthers, S. J. Lin, P. Brown et al., “Practical Value of Cardiac Magnetic Resonance Imaging for Clinical Quantification of Aortic Valve Stenosis: Comparison With Echocardiography,” Circulation, vol. 108, no. 18, pp. 2236–2243, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. R. Wyttenbach, J. Bremerich, M. Saeed, and C. B. Higgins, “Integrated MR imaging approach to valvular heart disease,” Cardiology Clinics, vol. 16, no. 2, pp. 277–294, 1998. View at Publisher · View at Google Scholar · View at Scopus
  88. F. Weidemann, S. Herrmann, S. Störk et al., “Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis,” Circulation, vol. 120, no. 7, pp. 577–584, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. A. D. Milano, G. Faggian, M. Dodonov et al., “Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis,” Journal of Thoracic and Cardiovascular Surgery, vol. 144, no. 4, pp. 830–837, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. C. W. L. Chin, H. J. Khaw, E. Luo et al., “Echocardiography underestimates stroke volume and aortic valve area: Implications for patients with small-area low-gradient aortic stenosis,” Canadian Journal of Cardiology, vol. 30, no. 9, pp. 1064–1072, 2014. View at Publisher · View at Google Scholar · View at Scopus
  91. S. J. Cowell, D. E. Newby, J. Burton et al., “Aortic valve calcification on computed tomography predicts the severity of aortic stenosis,” Clinical Radiology, vol. 58, no. 9, pp. 712–716, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. M.-A. Clavel, P. Pibarot, D. Messika-Zeitoun et al., “Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: Results of an international registry study,” Journal of the American College of Cardiology, vol. 64, no. 12, pp. 1202–1213, 2014. View at Publisher · View at Google Scholar · View at Scopus